Clinical Trial Update: Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating microwave ablation combined with cellular immunotherapy for hepatocellular carcinoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: COMPLETED